ONWD 1H 2026 revenue rises 250% YoY to €4.2M
ONWD reported 1H 2026 revenue up 250% year-over-year to €4.2M, citing strong ARCEX commercial uptake and pipeline progress. Cash balance reached €81.5M after raising over €40M in equity and securing a new €50M debt facility.
2M in 1H 2026, supported by stronger ARCEX commercial uptake and pipeline progress. 5M after the company raised over €40M in equity and secured a new €50M debt facility. The company said key clinical milestones and commercial launches are expected in the next 12 months.